Linda Neuman

Linda Neuman

Net worth: 5 195 $ as of 2024-04-29

59 year
Health Technology
Consumer Services

Network origin in Linda Neuman first degree

EntityEntity typeIndustry
Public Company Biotechnology 14
Public Company Pharmaceuticals: Major 4

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Linda Neuman via their personal network

CompanySectorRelated peopleMain position
CELGENE Biotechnology

Hunter Smith

Sandy Mahatme

Corporate Officer/Principal

Director of Finance/CFO

Biotechnology

Katherine Bock

Corporate Officer/Principal

ASTRAZENECA PLC Pharmaceuticals: Major

Anthony Quinn

Jim Kastenmayer

Corporate Officer/Principal

General Counsel

ASTROTECH CO. Aerospace & Defense

Charles York

Comptroller/Controller/Auditor

Agricultural Commodities/Milling

Hunter Smith

Public Communications Contact

Medical Specialties

Jeffrey Goldberg

Corporate Officer/Principal

LAZARD, INC. Investment Banks/Brokers

Katherine Bock

Corporate Officer/Principal

EVERCORE INC. Investment Banks/Brokers

Jonathan Alspaugh

Chief Executive Officer

HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Pharmaceuticals: Major

Michael Conick Hanley

Sales & Marketing

Michigan State University College/University

Jim Kastenmayer

Doctorate Degree

University of Virginia College/University

Jim Kastenmayer

Undergraduate Degree

OPTOS PLC Medical Specialties

Steven Schwartz

Director/Board Member

Massachusetts Institute of Technology College/University

Jeffrey Goldberg

Graduate Degree

Yale University College/University

Leslie Sloan

Doctorate Degree

College/University

Jeffrey Goldberg

Undergraduate Degree

San Francisco State University College/University

Katherine Bock

Undergraduate Degree

Southeastern Oklahoma State University College/University

Leslie Sloan

Undergraduate Degree

University of California, Berkeley College/University

Steven Schwartz

Undergraduate Degree

University of Connecticut College/University

Charles York

Undergraduate Degree

NEVRO CORP. Medical Specialties

Katherine Bock

Investor Relations Contact

IVERIC BIO, INC. Pharmaceuticals: Generic

Steven Schwartz

Director/Board Member

American Society of Retinal Specialists

Steven Schwartz

Director/Board Member

Other Consumer Services

Steven Schwartz

Corporate Officer/Principal

Pharmaceuticals: Major

Eugene Sackett

Human Resources Officer

Services to the Health Industry

Katherine Bock

Director/Board Member

Notre Dame University College/University

Michael Conick Hanley

Undergraduate Degree

The Wharton School of the University of Pennsylvania College/University

Katherine Bock

Sara Brownstein

Masters Business Admin

Undergraduate Degree

Georgetown University Law Center College/University

Jim Kastenmayer

Graduate Degree

Kellogg School of Management College/University

Michael Conick Hanley

Masters Business Admin

McCombs School of Business College/University

Charles York

Steven Weber

Masters Business Admin

Graduate Degree

MIT Sloan School of Management College/University

Jeffrey Goldberg

Jonathan Alspaugh

Masters Business Admin

Masters Business Admin

College/University

Steven Schwartz

Doctorate Degree

Medical Specialties

Steven Schwartz

Director/Board Member

Packaged Software

Steven Schwartz

Director/Board Member

AKCEA THERAPEUTICS, INC. Pharmaceuticals: Major

Amber Salzman

Jeffrey Goldberg

Director/Board Member

Chief Operating Officer

IGM BIOSCIENCES, INC. Pharmaceuticals: Major

Steven Weber

Comptroller/Controller/Auditor

ARCUS BIOSCIENCES, INC. Biotechnology

Katherine Bock

Investor Relations Contact

PRAXIS PRECISION MEDICINES, INC. Pharmaceuticals: Major

Marcio Souza

Chief Executive Officer

Biotechnology

Sara Brownstein

Director/Board Member

VIELA BIO, INC. Biotechnology

Jim Kastenmayer

General Counsel

Biotechnology

Leslie Sloan

President

Pharmaceuticals: Other

Michael Conick Hanley

Corporate Officer/Principal

Biotechnology

Jeffrey Goldberg

Chief Executive Officer

Pharmaceuticals: Major

Charles York

Director of Finance/CFO

DAY ONE BIOPHARMACEUTICALS, INC. Pharmaceuticals: Major

Charles York

Director of Finance/CFO

ARRIVENT BIOPHARMA, INC. Pharmaceuticals: Major

Jim Kastenmayer

General Counsel

ALTO NEUROSCIENCE, INC. Biotechnology

Michael Conick Hanley

Chief Operating Officer

Statistics

International

United States 45
United Kingdom 3
Ireland 2
Lebanon 2
Spain 2

Sectoral

Health Technology 27
Consumer Services 17
Finance 4
Electronic Technology 2
Process Industries 2

Operational

Director/Board Member 40
Corporate Officer/Principal 24
Undergraduate Degree 16
Independent Dir/Board Member 15
Chief Executive Officer 15